Yasmin and Bactroban drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Yasmin (drospirenone; ethinyl estradiol) and Bactroban (mupirocin). Common drug interactions include pulmonary embolism among females and amnesia among males.

The phase IV clinical study analyzes what interactions people have when they take Yasmin and Bactroban. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.

What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,967 Bactroban users. Check the latest studies of Bactroban.



On Jul, 21, 2026

32 people who take Yasmin and Bactroban together, and have interactions are studied.

Yasmin and Bactroban drug interactions.

What are the common drug interactions of Yasmin and Bactroban, by gender? *:

female:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Asthenia (weakness)
  5. Attention deficit/hyperactivity disorder
  6. Axillary vein thrombosis (formation of a blood clot in axillary vein)
  7. Balance disorder
  8. Pain
  9. Injury
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Cerebral venous thrombosis (clot in brains venous blood system)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Confusional state
  5. Headache (pain in head)
  6. Muscular weakness (muscle weakness)
  7. Pain
  8. Spinal column stenosis (narrowing of spinal column)
  9. Spinal fusion surgery

What are the common drug interactions of Yasmin and Bactroban, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Pain
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Dyspnoea (difficult or laboured respiration)
  6. Injury
  7. Pain in extremity
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Gallbladder disorder
  10. Gallbladder pain

20-29:

  1. Muscle spasms (muscle contraction)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Cardiac disorder
  5. Renal disorder (kidney disease)
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Atelectasis (partial or complete collapse of the lung)
  9. Attention deficit/hyperactivity disorder
  10. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Abdominal pain upper
  4. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  5. Brain injury
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Cholecystitis chronic (long lasting infection of gallbladder)
  9. Cholesterosis (abnormal deposition of cholesterol in tissues)
  10. Injury

40-49:

  1. Axillary vein thrombosis (formation of a blood clot in axillary vein)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Subclavian vein thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein)
  4. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)

50-59:

  1. Mesenteric vein thrombosis (blood clot in mesenteric vein)
  2. Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
  3. Splenic vein thrombosis (blood clot in splenic vein)

60+:

  1. Pain
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
  4. Injury
  5. Pleural effusion (water on the lungs)
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the existing conditions these people have? *

  1. Pain: 7 people, 21.88%
  2. Depression: 5 people, 15.62%
  3. Stress And Anxiety: 4 people, 12.50%
  4. Premenstrual Syndrome: 4 people, 12.50%
  5. Nausea (feeling of having an urge to vomit): 3 people, 9.38%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.38%
  7. Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 3 people, 9.38%
  8. Menstruation Irregular: 2 people, 6.25%
  9. Diabetes: 2 people, 6.25%
  10. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Yasmin and Bactroban?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Yasmin and Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Yasmin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactroban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on drospirenone; ethinyl estradiol and mupirocin (the active ingredients of Yasmin and Bactroban, respectively), and Yasmin and Bactroban (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: